ABSTRACT To the extent that calcium availability is the final common mediator of vasoconstrictor responses, calcium entry blockade might interfere with physiologic responses to adrenergic stimulation. To test this hypothesis, we studied the effects of calcium entry blockade on pressor responses to norepinephrine in pithed, normal Sprague-Dawley rats in two different ways: (1) by evaluating the effects on pressor responsiveness to exogenous norepinephrine during differential blockade of al-(prazosin, 0.3 mg/kg) and of a2-receptors (yohimbine, 0.3 mg/kg) and (2) by comparing the effects of calcium entry blockade with those of prazosin and those of rauwolscine (a specific a2-antagonist) on pressor responses to infusions of both endogenously released norepinephrine (electrical stimulation of the pithing rod) and exogenous norepinephrine. In the presence of a, -blockade, both nitrendipine (0.01 mg/kg) and verapamil (0.6 mg/kg) shifted the norepinephrine pressor dose-response curve to the right but were ineffective in a2-blocked animals. Furthermore, nitrendipine (range 0.01 to 0.3 mg/kg) proved to be more effective (p < .001) against exogenous norepinephrine than against electrical stimulation of the spinal cord, a behavior opposite that of selective a,-blockade (prazosin) and directionally comparable to that of selective a2-antagonism (rauwolscine). These data indicate that calcium entry blockade in vivo preferentially antagonizes the ca2-pressor component of exogenous norepinephrine. In addition, both calcium entry blockers were consistently more active (p < .01) than rauwolscine (0.01 to 1 mg/kg) in antagonizing the pressor response to neural stimulation, suggesting that mechanisms different from "classical" a2-antagonism may also contribute to the overall effect of calcium entry blockade on the adrenergic control Circulation 69, No. 6, 117169, No. 6, -117669, No. 6, , 1984 
of peripheral vascular tone.
for intracellular entry of external calcium ions and (2) release of intracellular calcium from its storage sites.
This suggests that pharmacologic interference with calcium influxes could therefore impair vasoconstrictor responses to a-adrenergic stimulation in proportion to the relative dependence of adrenergic responsiveness on extracellular calcium concentrations.
This study was designed to test that inference by analyzing the effects of calcium entry blockade on pressor responses to norepinephrine. The pressor responses were induced by exogenous administration and endogenous release by electrical nerve stimulation; in both cases the relative a,-and a2-components of the responses4' 5 were dissected out by the use of specific antagonists for each receptor subtype. Furthermore, because of the heterogeneity of calcium entry blockers, we chose two chemically unrelated cal-PEDRINELLI and TARAZI cium antagonists, verapamil' and nitrendipine,6 both of which were used in concentrations close to those used in therapeutic doses.78
Materials and methods
Animal preparation. Female Sprague-Dawley rats (body weight 200 to 250 g), purchased from Hilltop Laboratory, Scottsdale, NJ, were allowed to stabilize for several days before the experiments. Under anesthesia with ether, the animals were pithed through the orbit by a blunt steel needle (2.0 mm in diameter) and immediately ventilated artificially (60 strokes/ min, 1 ml/100 g body weight of room air). This procedure destroys the entire central nervous system but leaves intact the emerging nerve trunks.9 Both vagi were cut in the neck and the right carotid artery was cannulated for recording blood pressure and heart rate. The rats were kept warm by a lamp positioned about 30 cm above the chest and were allowed to recover for 45 to 60 min from the effects of spinal shock and anesthesia. All drugs were given in bolus form flushed with 0.05 ml saline; all were injected through the femoral vein except for verapamil, which had to be given intra-arterially (left carotid) because pilot studies showed that severe bradycardia and death followed its direct intravenous injection.
Experimental procedure Agonist dose-response curves. Cumulative dose-response curves to norepinephrine were obtained as recently described by Cavero et al. ' 0 Increasing doses of norepinephrine (increments of 0.5 log units) were given, each one after the preceding dose had produced its maximum effect. Pilot experiments confirmed that this method more rapidly produces results that are virtually identical to those of the single injection method.'0 A standard dose of norepinephrine (0.2 ,ug/kg) was given before each doseresponse curve to ensure that the responsiveness of all preparations were comparable with each other. When an antagonist had to be used in these studies, it was injected at least 15 min before determination of the dose-response curve.
Antagonist dose-response curves. The responsiveness of the preparation was first tested as follows: (1) For experiments with exogenous norepinephrine, the agonist was given at a dose (between 0.2 and 0.4 pg/kg) calculated from previous experiments in our laboratory to raise diastolic blood pressure by 45 to 55 mm Hg, about 50% of the maximum pressure response. (2) In experiments with electrical stimulation, another steel rod (indifferent electrode) was by rauwolscine (dose range 0.01 to 1.0 mg/kg). Rauwolscine was chosen because it had been shown to maintain its selective antagonism even at the highest doses used. 13 Six groups of rats were studied, two for each drug (n = 6 for prazosin and for nitrendipine, n -5 for rauwolscine).
Series 4. To further characterize the effect of calcium entry blockade on the responses to neural stimulation, verapamil (dose range 0.01 to 0.3 mg/kg was used. The results, along with those obtained with nitrendipine (series 3), were then compared with those obtained by rauwolscine administration against the same stimulus (series 3).
Drugs. dl-Propranolol HCl (Inderal; Ayerst) was obtained from commercially available ampules. Solutions of yohimbine HCI (Aldrich), rauwolscine HCl (Accurate Chemicals), prazosin HCl (Pfizer, Inc.), nitrendipine (Miles Laboratories), verapamil HCI (Knoll, Inc.), and l-norepinephrine bitartrate (Levophed; Breon Laboratory) were prepared fresh each day. Nitrendipine was solubilized in propylene glycol and injected in boluses not exceeding 8 ul; this volume of solvent did not induce any change in blood pressure or heart rate as documented in preliminary experiments. The vials containing the drug were wrapped in aluminum foil to avoid contact with light. With the exception of nitrendipine, all doses of drugs refer to their respective salts.
Analysis of results Agonist dose-response curves. The absolute increments in diastolic blood pressure were computed and plotted on semilogarithmic scale. The individual dose-response curves were then interpolated by a logistic function'4 to obtain the estimated ED50 values; the differences between groups were then tested by the Mann-Whitney ran ues (expressed as geor of the various antagol dose-response curves.
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Effect Lk <.5 n hsefc nrae rgsieywt higher doses ( figure 3 ). Under the same experimental conditions, verapamil (figure 4) at lower doses (0.01 and 0.03 mg/kg) was ineffective against the same stimulation but exerted a significant antagonism at higher doses (-15.2 + 4.8%; p < .05 at 0.1 mg/kg and -30.9 ± 9.7%; p < .01 at 0.3 mg/kg). The effects of rauwolscine on pressor responses to neural stimulation was quite different from those of verapamil and of nitrendipine (figure 4); this was observed whether the doses administered were expressed in milligrams or in molecular weight (figure 4).
Discussion
The results obtained in this series of studies indicate that calcium entry blockade by either nitrendipine or verapamil interfered effectively with pressor responses to infused norepinephrine when the a2-adrenergic sites were left exposed (pretreatment with prazosin and propranolol); they did not significantly antagonize these responses in the group pretreated with propranolol and yohimbine, in which presumably only the a,-adrenergic receptors were exposed. These effects were probably not due to binding of the drugs to the a2-receptors. It has been shown that dihydropyridine calcium entry blockers do not bind to either aC,-or a2-receptor These conclusions are supported by the results obtained in subsequent studies comparing the effects of prazosin and nitrendipine on pressor responses to exogenous and endogenously released norepinephrine. Nitrendipine was less potent against the pressor responses evoked by neural stimulation than against responses to exogenous norepinephrine a pattern distinctly opposite that resulting from a,-blockade but similar to the effects of rauwolscine, a specific a2-antagonist (figure 3). These findings are consistent with preferential antagonism of a2-mediated vasoconstriction by the calcium entry blocker because circulating norepinephrine also activates a2-receptors4 12 while neural stimulation, at least in the rat'2 21 22 and probably in other species,23 uses this pathway to only a minor extent. In direct confirmation of this concept are .N H_. blockade of transneurolemmal calcium influx.29 However, this may not apply to all situations because results of experiments in vitro indicated that very high doses of calcium entry blockers were needed to decrease neurotransmitter release.3032 These data were obtained from cardiac preparations30 31 and isolated vessels32 and might not necessarily hold for the whole vascular tree or situations in vivo. Further work is also needed to evaluate the effect of calcium entry blockade on the mechanisms of presynaptic a2-regulation as compared with its effect on postsynaptic responses and on ganglionic transmission.
In conclusion, our data show that two chemically unrelated calcium entry blockers, nitrendipine and verapamil, antagonized the pressor responses to exogenous norepinephrine by preferential a2-postsynaptic antagonism. In addition, when tested against responses mediated by endogenously released norepinephrine, both drugs behaved differently from a specific a2-antagonist, rauwolscine. Thus other actions such as interference with neurotransmitter release could also take part in the complex effect of calcium entry blockade on neural control of peripheral vascular tone.
